These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15959653)

  • 21. The uptake and outcome of prenatal and pre-implantation genetic diagnosis for Huntington's disease in the Netherlands (1998-2008).
    van Rij MC; de Koning Gans PA; van Belzen MJ; Roos RA; Geraedts JP; De Rademaeker M; Bijlsma EK; de Die-Smulders CE
    Clin Genet; 2014 Jan; 85(1):87-95. PubMed ID: 23350580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive DNA-testing for Huntington's disease and reproductive decision making: a European collaborative study.
    Evers-Kiebooms G; Nys K; Harper P; Zoeteweij M; Dürr A; Jacopini G; Yapijakis C; Simpson S
    Eur J Hum Genet; 2002 Mar; 10(3):167-76. PubMed ID: 11973620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'You don't make genetic test decisions from one day to the next'--using time to preserve moral space.
    Scully JL; Porz R; Rehmann-Sutter C
    Bioethics; 2007 May; 21(4):208-17. PubMed ID: 17845479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The roles of family members, health care workers, and others in decision-making processes about genetic testing among individuals at risk for Huntington disease.
    Klitzman R; Thorne D; Williamson J; Marder K
    Genet Med; 2007 Jun; 9(6):358-71. PubMed ID: 17575502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Norwegian procedure in connection with presymptomatic testing for Huntington disease].
    Helle JR; Braathen GJ; Pedersen JC; Stokke B; Berg K
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2417. PubMed ID: 11475228
    [No Abstract]   [Full Text] [Related]  

  • 26. A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice.
    Wadrup F; Holden S; MacLeod R; Miedzybrodzka Z; Németh AH; Owens S; Pasalodos S; Quarrell O; Clarke AJ;
    Eur J Hum Genet; 2019 Aug; 27(8):1215-1224. PubMed ID: 30890781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive gene testing for Huntington disease and other neurodegenerative disorders.
    Wedderburn S; Panegyres PK; Andrew S; Goldblatt J; Liebeck T; McGrath F; Wiltshire M; Pestell C; Lee J; Beilby J
    Intern Med J; 2013 Dec; 43(12):1272-9. PubMed ID: 23654213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prenatal exclusion test for Huntington's disease: experience in the west of Scotland, 1986-1993.
    Tolmie JL; Davidson HR; May HM; McIntosh K; Paterson JS; Smith B
    J Med Genet; 1995 Feb; 32(2):97-101. PubMed ID: 7760329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive deliberation: Supporting autonomous decision making in prenatal genetic counseling.
    Warton C; Johnston M; Mills C
    J Genet Couns; 2023 Jun; 32(3):576-583. PubMed ID: 36765016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproductive decision-making: a qualitative study among couples at increased risk of having a child with retinoblastoma.
    Dommering CJ; van den Heuvel MR; Moll AC; Imhof SM; Meijers-Heijboer H; Henneman L
    Clin Genet; 2010 Oct; 78(4):334-41. PubMed ID: 20618349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Huntington's disease.
    Craufurd D
    Prenat Diagn; 1996 Dec; 16(13):1237-45. PubMed ID: 9061754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results.
    Semaka A; Hayden MR
    Clin Genet; 2014 Apr; 85(4):303-11. PubMed ID: 24256063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision making in Huntington's disease and cystic fibrosis.
    Evers-Kiebooms G
    Birth Defects Orig Artic Ser; 1987; 23(2):115-49. PubMed ID: 2885041
    [No Abstract]   [Full Text] [Related]  

  • 34. Ethical issues in prenatal testing.
    Burgess MM
    Clin Biochem; 1994 Apr; 27(2):87-91. PubMed ID: 8070072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The right to ignore genetic status of late onset genetic disease in the genomic era; Prenatal testing for Huntington disease as a paradigm.
    Erez A; Plunkett K; Sutton VR; McGuire AL
    Am J Med Genet A; 2010 Jul; 152A(7):1774-80. PubMed ID: 20583190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethical considerations in the social context of Huntington disease.
    Turner D
    Dis Markers; 1992; 10(4):171-83; discussion 211-28. PubMed ID: 1304435
    [No Abstract]   [Full Text] [Related]  

  • 37. Utilisation of predictive, prenatal and diagnostic testing for Huntington's disease in Johannesburg.
    Kromberg JG; Krause A; Spurdle AB; Temlett JA; Lucas M; Rodseth D; Stevens G; Jenkins T
    S Afr Med J; 1999 Jul; 89(7):774-8. PubMed ID: 10470316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetic counseling in presymptomatic testing for Huntington disease].
    Helle JR; Braathen GJ; Pedersen JC; Skodje T; Stokke B; Berg K
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2412-6. PubMed ID: 11475227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presymptomatic, prenatal, and exclusion testing for Huntington disease using seven closely linked DNA markers.
    Skraastad MI; Verwest A; Bakker E; Vegter-van der Vlis M; van Leeuwen-Cornelisse I; Roos RA; Pearson PL; van Ommen GJ
    Am J Med Genet; 1991 May; 39(2):217-22. PubMed ID: 1829584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic risk for Huntington Disease and reproductive decision-making: A systematic review.
    Fahy N; Rice C; Lahiri N; Desai R; Stott J
    Clin Genet; 2023 Aug; 104(2):147-162. PubMed ID: 37095632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.